Wuxi Advanced Therapies, A Wholly Owned Subsidiary Of Wuxi Apptec, Announced A Licensing Agreement With Janssen Biotech, Inc., One Of The Janssen Pharmaceutical Companies Of Johnson & Johnson (Janssen).Under This Agreement, Wuxi Atu Will License To Janssen Its Tessa Technology, A High-Performance System That Can Produce 10 Times More Adeno-Associated Viral (Aav) Vectors Than Traditional Aav Manufacturing Systems. Janssen Will Also Have Access To Work On Wuxi Atu'S Proprietary Clonal Suspension Hek293 Cell Line. This Agreement Was Facilitated By Johnson & Johnson Innovation.Aav Vectors Are Commonly Used For The Delivery Of Gene Therapies To Patients Due To Their Ability To Transduce Numerous Cell And Tissue Types. Wuxi Atu'S Tessa Technology Responds To Industry Demand For Large Scale Aav Manufacturing By Producing Higher Quality Aav Particles More Efficiently. Wuxi Atu Has Also Successfully Scaled Up The Tessa Technology To 200L; This Achieved A 10-Fold Higher Yield And A Significantly Higher Percentage Of Full Aav Capsids, Greatly Reducing Overall Aav Production Costs Compared To Traditional Plasmid-Based Aav Production Systems."We Are Honored That Janssen Selected Wuxi Atu'S Tessa Technology." Said Dr. David Chang, Chief Executive Officer Of Wuxi Advanced Therapies. "We Remain Committed To Improving The Tessa Platform To Produce Faster And More Cost-Effective Aav Products For Patients."As A Contract Testing, Development And Manufacturing Organization (Ctdmo) With Global Operations, Wuxi Atu Will Continue To Enhance Its Capability And Capacity To Help Customers Develop And Deliver Life-Changing Cell And Gene Therapies Faster For Patients In Need.As The Advanced Therapies Business Unit Of Wuxi Apptec, Wuxi Advanced Therapies Is A Contract Testing, Development And Manufacturing Organization (Ctdmo) That Offers Integrated Platforms To Transform The Discovery, Development, Testing, Manufacturing, And Commercialization Of Cell And Gene Therapies.As A Global Company With Operations Across Asia, Europe, And North America, Wuxi Apptec Provides A Broad Portfolio Of R&D And Manufacturing Services That Enable Global Pharmaceutical And Healthcare Industry To Advance Discoveries And Deliver Groundbreaking Treatments To Patients.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!